Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Helman

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Nature Medicine|May 19, 1998
Glimpsing the cause of rhabdomyosarcomaS Zhan, L J Helman
Oncogene|September 28, 1999
Rhabdomyosarcoma--working out the pathwaysG Merlino, L J Helman
Current Opinion in Oncology|July 1, 1997
Cytogenetics and experimental modelsJ A Toretsky, L J Helman
Pediatric Clinics of North America|April 1, 1991
New insights into the causes of cancerL J Helman, C J Thiele
Journal of Pediatric Hematology/Oncology|July 24, 2001
High-dose chemotherapy for rhabdomyosarcoma: where do we go from hereC L Mackall, L J Helman
The Journal of Endocrinology|June 1, 1996
Involvement of IGF-II in human cancerJ A Toretsky, L J Helman
Cancer Research|September 15, 1991
All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell linesG D Crouch, L J Helman
Current Oncology Reports|December 21, 2000
Targeting pediatric malignancies for T cell-mediated immune responsesC L Mackall, L J Helman
CA: a Cancer Journal for Clinicians|July 1, 1994
Pediatric soft tissue sarcomasL H Wexler, L J Helman
Advances in Experimental Medicine and Biology|January 1, 1993
IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesisC P Minniti, L J Helman
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Nature Medicine|May 19, 1998
Glimpsing the cause of rhabdomyosarcomaS Zhan, L J Helman
Oncogene|September 28, 1999
Rhabdomyosarcoma--working out the pathwaysG Merlino, L J Helman
Current Opinion in Oncology|July 1, 1997
Cytogenetics and experimental modelsJ A Toretsky, L J Helman
Pediatric Clinics of North America|April 1, 1991
New insights into the causes of cancerL J Helman, C J Thiele
Journal of Pediatric Hematology/Oncology|July 24, 2001
High-dose chemotherapy for rhabdomyosarcoma: where do we go from hereC L Mackall, L J Helman
The Journal of Endocrinology|June 1, 1996
Involvement of IGF-II in human cancerJ A Toretsky, L J Helman
Cancer Research|September 15, 1991
All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell linesG D Crouch, L J Helman
Current Oncology Reports|December 21, 2000
Targeting pediatric malignancies for T cell-mediated immune responsesC L Mackall, L J Helman
CA: a Cancer Journal for Clinicians|July 1, 1994
Pediatric soft tissue sarcomasL H Wexler, L J Helman
Advances in Experimental Medicine and Biology|January 1, 1993
IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesisC P Minniti, L J Helman
Pageof 8